You are most cordially invited to the ICTP Colloquium "Development of Novel Radionuclides for New Emerging Medical Applications" by Syed M. Qaim from the Institute of Neuroscience and Medicine (INM), Germany.
The Colloquium will take place on Wednesday 4 November 2026 in the Budinich Lecture Hall at ICTP at 4:00PM CET. Light refreshments will be served at end of the event in the Leonardo Building entrance hall.
The production technology of reactor- and cyclotron-based radionuclides, routinely used in patient care, encompassing about 60 million cases worldwide per year, is generally well established. However, to meet demands of some new emerging medical applications, such as bimodal imaging, theranostic approach or radioimmunotherapy, novel radionuclides with versatile labelling chemistry are needed. In great demand are presently longer-lived non-standard positron emitters for diagnosis and low-energy highly-ionising β-- and α-particle emitters for therapy Special interest lies presently in the radionuclide targeted therapy. This talk gives an overview of new research trends in production of novel medical radionuclides. The relevant areas of investigation include nuclear data, high current irradiation technology, chemical processing and quality assurance of the radioactive product. A few examples from each area will be given, based on the use of the following existing and emerging technical facilities.
For info, please check the following link: https://indico.ictp.it/event/11554/
Looking forward to your participation.
With best regards,
Director's Office, ICTP